Wordt geladen...
Technology evaluation: Kahalalide F, PharmaMar
Kahalalide F is a depsipeptide under development by PharmaMar as a potential treatment for solid tumors. It is currently undergoing phase II clinical trials.
Bewaard in:
Gepubliceerd in: | Curr Opin Mol Ther |
---|---|
Hoofdauteur: | |
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
2004
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4941207/ https://ncbi.nlm.nih.gov/pubmed/15663330 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|